Journal Title：Clinical And Translational Medicine

Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

《臨床與轉(zhuǎn)化醫(yī)學》（CTM）是一本國際性、同行評審和開放獲取的期刊，旨在促進和加速臨床前研究向臨床應用的轉(zhuǎn)化，以及基礎(chǔ)科學家和臨床科學家之間的交流。該期刊強調(diào)新生物技術(shù)、生物材料、生物工程、疾病特異性生物標志物、細胞和分子醫(yī)學、組學科學、生物信息學、應用免疫學、分子成像、藥物發(fā)現(xiàn)和開發(fā)以及法規(guī)和衛(wèi)生政策的臨床潛力和應用。該期刊專注于從實驗室到臨床的方法，支持產(chǎn)生與患者和疾病相關(guān)的假設(shè)和問題的研究和臨床觀察，并指導細胞和分子醫(yī)學的研究?！杜R床與轉(zhuǎn)化醫(yī)學》歡迎臨床醫(yī)生、研究人員、政策制定者和行業(yè)的投稿。

Clinical And Translational Medicine創(chuàng)刊于2012年，由Wiley出版商出版，收稿方向涵蓋Multiple全領(lǐng)域，在行業(yè)領(lǐng)域中學術(shù)影響力很大，屬于國際一流期刊，關(guān)注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于一流期刊，建議關(guān)注此刊。平均審稿速度 4 Weeks ，影響因子指數(shù)7.9，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。